Geode Capital Management »

Fibrobiologics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Fibrobiologics shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $39k 30k 1.32

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Meta Platforms Inc-class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Visa Inc-class A Shares Com Cl A (V)

View all positions for Geode Capital Management

Top funds holding Fibrobiologics

Vanguard Capital Management
Fund Evaluation Group
Geode Capital Management
BlackRock
Cascade Financial Partners
Vanguard Fiduciary Trust
UBS Group
Goss Wealth Management
Vanguard Global Advisers
Western Wealth Management
Royal Bank of Canada
Islay Capital Management
Bnp Paribas Arbitrage, Snc
Wells Fargo & Company

View all funds holding Fibrobiologics